Cure Pharmaceutical
Oxnard
About Cure Pharmaceutical
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin films on the market today. CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $29.7M
- Funding stage: IPO
- Last round: Debt Financing (Sep 2022)
- Ticker: otcpink:CURR
- Website: curepharmaceutical.com
- Phone: 1(805)824-0410
Industries & Categories
Biotechnology, Cannabis, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cure-pharmaceutical-168002 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.